Randomized Phase II/III Trial of Second Line Chemotherapy Comparing CPT-11 Monotherapy Versus S-1/CPT-11 Combination for S-1 Refractory Gastric Cancer
Phase of Trial: Phase II/III
Latest Information Update: 24 Jun 2015
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Jan 2014 Primary endpoint 'Overall-survival-duration' has not been met.
- 18 Jan 2014 Results presented at the 2014 Gastrointestinal Cancers Symposium.
- 11 Sep 2013 The Japan Clinical Cancer Research Organization (JACCRO) will further investigate the data and make a detailed announcement of the results at a medical conference in 2014, according to a Taiho Pharmaceutical media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History